These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21703185)

  • 1. Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway.
    Kudo Y; Tanaka Y; Tateishi K; Yamamoto K; Yamamoto S; Mohri D; Isomura Y; Seto M; Nakagawa H; Asaoka Y; Tada M; Ohta M; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Maeda S; Shiina S; Yoshida H; Nakajima O; Kanai F; Omata M; Koike K
    J Hepatol; 2011 Dec; 55(6):1400-8. PubMed ID: 21703185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.
    Hoekstra M; Li Z; Kruijt JK; Van Eck M; Van Berkel TJ; Kuiper J
    J Hepatol; 2010 Feb; 52(2):244-51. PubMed ID: 20015565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.
    Vinciguerra M; Carrozzino F; Peyrou M; Carlone S; Montesano R; Benelli R; Foti M
    J Hepatol; 2009 Jun; 50(6):1132-41. PubMed ID: 19398230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.
    Morán-Salvador E; López-Parra M; García-Alonso V; Titos E; Martínez-Clemente M; González-Périz A; López-Vicario C; Barak Y; Arroyo V; Clària J
    FASEB J; 2011 Aug; 25(8):2538-50. PubMed ID: 21507897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage.
    Hughes DE; Stolz DB; Yu S; Tan Y; Reddy JK; Watkins SC; Diehl AM; Costa RH
    Hepatology; 2003 Jun; 37(6):1414-24. PubMed ID: 12774021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism.
    Vinciguerra M; Veyrat-Durebex C; Moukil MA; Rubbia-Brandt L; Rohner-Jeanrenaud F; Foti M
    Gastroenterology; 2008 Jan; 134(1):268-80. PubMed ID: 18166358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?
    Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM
    Cancer Res; 2001 Jul; 61(13):5016-23. PubMed ID: 11431335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Nakatsuka T; Tateishi K; Kudo Y; Yamamoto K; Nakagawa H; Fujiwara H; Takahashi R; Miyabayashi K; Asaoka Y; Tanaka Y; Ijichi H; Hirata Y; Otsuka M; Kato M; Sakai J; Tachibana M; Aburatani H; Shinkai Y; Koike K
    Oncogene; 2017 Nov; 36(45):6262-6271. PubMed ID: 28692045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
    Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
    Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
    Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
    J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
    Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
    J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse.
    Chow JD; Jones ME; Prelle K; Simpson ER; Boon WC
    J Endocrinol; 2011 Sep; 210(3):323-34. PubMed ID: 21705395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.
    Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL
    Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):973-83. PubMed ID: 19307976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver.
    Rasooly R; Kelley DS; Greg J; Mackey BE
    Br J Nutr; 2007 Jan; 97(1):58-66. PubMed ID: 17217560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.